Best treatments for kidney neoplasms
9 products may treat kidney neoplasms, spanning FDA drug classes such as vascular endothelial growth factor inhibitor, alkylating drug, programmed death receptor-1 blocking antibody. The current highest-rated option is alymsys. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 9 drugs we list for kidney neoplasms, none are yet flagged as generics in our price data, spanning classes such as vascular endothelial growth factor inhibitor, alkylating drug, programmed death receptor-1 blocking antibody. 5 of 9 carry a safety score, from 72 to 72 out of 100. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for kidney neoplasms — so confirm the right choice with your prescriber.
Top-rated picks for kidney neoplasms: 1. Alymsys · 2. Avastin · 3. Gleostine
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Injectable | — | No data | — | View → | |
| 2 | 72/100 | Prescription | Injectable | Vascular Endothelial Growth Factor Inhibitor | No data | — | View → | |
| 3 | 72/100 | Prescription | Capsule | Alkylating Drug | No data | — | View → | |
| 4 | 72/100 | Prescription | Injectable | — | No data | — | View → | |
| 5 | 72/100 | Prescription | Injectable | Programmed Death Receptor-1 Blocking Antibody | No data | — | View → | |
| 6 | Not yet rated | Prescription | Injectable | — | No data | — | View → | |
| 7 | Not yet rated | Prescription | Injectable | — | No data | — | View → | |
| 8 | Not yet rated | Prescription | Capsule | Alkylating Drug | No data | — | View → | |
| 9 | Not yet rated | Prescription | Injectable | — | No data | — | View → |
Narrow by drug class
Explore the class hubs: alkylating drug
Full ranking · 9 treatments
alymsys
PrescriptionFDA-sourced
Alymsys (Bevacizumab-Maly) is a medication used to treat Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Glioblastoma.
Price varies
avastin
PrescriptionFDA-sourced
Avastin (Bevacizumab) is a vascular endothelial growth factor inhibitor used to treat Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Glioblastoma.
Price varies
gleostine
Boxed warningPrescriptionFDA-sourced
Gleostine (Lomustine) is an alkylating drug used to treat Brain Neoplasms, Colonic Neoplasms, Hodgkin Disease, Kidney Neoplasms.
Price varies
mvasi
PrescriptionFDA-sourced
Mvasi (Bevacizumab-Awwb) is a medication used to treat Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Glioblastoma.
Price varies
opdivo
PrescriptionFDA-sourced
Opdivo (Nivolumab) is a programmed death receptor-1 blocking antibody used to treat Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Squamous Cell Carcinoma, Kidney Neoplasms.
Price varies
avzivi
PrescriptionFDA-sourced
Avzivi (Bevacizumab-Tnjn) is a medication used to treat Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Glioblastoma.
Price varies
Frequently asked
- What treats kidney neoplasms?
- Our catalog lists 9 products that may treat kidney neoplasms, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is alymsys.
- What is the best-rated treatment for kidney neoplasms?
- By our independent recall-safety rating — not an efficacy measure — alymsys ranks highest among the products we list for kidney neoplasms. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat kidney neoplasms?
- Treatments for kidney neoplasms span FDA drug classes including vascular endothelial growth factor inhibitor, alkylating drug, programmed death receptor-1 blocking antibody. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Where this ranking comes from
Our score is computed from public FDA data — not from opinion, sponsorship or user votes. How we rate.
- FDA Drug Enforcement (recall) database — the recall history behind the safety score
- DailyMed (NIH National Library of Medicine) — the FDA labels we quote for uses, dosing and warnings
- Drugs@FDA — approvals, strengths and marketing status